KRT222: A Potential Drug Target and Biomarker (G125113)

Target Name: KRT222

NCBI ID: G125113

KRT222

KRT222: A Potential Drug Target and Biomarker

Krtin 222 (keratin 222 pseudogene) is a gene that encodes a protein known as Krtin 222. This protein plays a crucial role in the development and maintenance of hair and nails, and is a key component of the cytoskeleton. Krtin 222 has also been shown to be involved in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, Krtin 222 has potential as a drug target and biomarker.

The Hair and Nail Cycle

Krtin 222 is a protein that is involved in the development and maintenance of hair and nails. This protein helps to regulate the growth and differentiation of cells in the hair and nail follicles, and is essential for the formation of these structures. Krtin 222 is also involved in the regulation of cell division and differentiation, as well as in the formation of the cytoskeleton.

In addition to its role in the hair and nail cycle, Krtin 222 has also been shown to be involved in the regulation of cell signaling pathways. This includes the regulation of the signal transduction pathway, which is a critical pathway that involves the interaction between cells and their signaling systems.

The Role of Krtin 222 in Cancer

Krtin 222 has been shown to be involved in the regulation of cell proliferation, which is a critical aspect of cancer development. In fact, Krtin 222 has been shown to play a role in the regulation of cell cycle progression, as well as in the development of cancer. For example, studies have shown that Krtin 222 is involved in the regulation of mitosis, which is the process by which a cell divides.

In addition to its role in cancer development, Krtin 222 has also been shown to be involved in the regulation of cell survival. This is important because the regulation of cell survival is critical for the development and maintenance of cancer.

The Neurodegenerative Diseases

Krtin 222 has also been shown to be involved in the development and progression of neurodegenerative diseases. These are a group of serious diseases that are characterized by the progressive loss of brain cells and the development of progressive neurofunctional disorders.

Krtin 222 has been shown to play a role in the regulation of neurotransmitter synthesis and release, which is the process by which neurons communicate with one another. This is important because the regulation of neurotransmitter synthesis and release is critical for the function of the nervous system.

The Autoimmune Disorders

Krtin 222 has also been shown to be involved in the development and progression of autoimmune disorders. These are a group of serious diseases that are characterized by the immune system attacking the body's own tissues and causing inflammation.

Krtin 222 has been shown to play a role in the regulation of immune cell function, which is the process by which the immune system responds to the presence of foreign substances in the body. This is important because the regulation of immune cell function is critical for the development and progression of autoimmune disorders.

Potential Drug Target

The potential use of Krtin 222 as a drug target is based on its involvement in the regulation of cell proliferation, neurotransmission, and immune cell function. This means that Krtin 222 could be an effective target for the development of drugs that are designed to treat a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its potential as a drug target, Krtin 222 has also been shown to be

Protein Name: Keratin 222

The "KRT222 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT222 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets